Lee, H. C., Bumma, N., Richter, J. R., Zonder, J. A., Hoffman, J. E., Zhou, Z., Horton, V. G., Fillbrunn, M., Wang, H., Mattera, M., Ma, W., Inocencio, T., Xu, Y., Harnett, J., Roccia, T., Knorr, K., Kroog, G. S., Lorenc, K. R., Ma, Q., Jagannath, S. (2026). Comparative efficacy of linvoseltamab versus teclistamab in triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM): Updated matching-adjusted indirect comparison (MAIC) with longer follow-up.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.7526